Robert M. Immormino
Duke University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert M. Immormino.
Acta Crystallographica Section D-biological Crystallography | 2010
Vincent B. Chen; W. Bryan Arendall; Jeffrey J. Headd; Daniel A. Keedy; Robert M. Immormino; Gary J. Kapral; Laura Weston Murray; Jane S. Richardson; David C. Richardson
MolProbity structure validation will diagnose most local errors in macromolecular crystal structures and help to guide their correction.
Journal of Biological Chemistry | 2005
D. Eric Dollins; Robert M. Immormino; Daniel T. Gewirth
GRP94, the endoplasmic reticulum paralog of Hsp90, is regulated by adenosine nucleotides that bind to its N-terminal regulatory domain. Because of its weak affinity for nucleotides, the functionally relevant transition in GRP94 is likely to be between the unliganded and nucleotide-bound states. We have determined the structure of the unliganded GRP94 N-domain. The helix 1-4-5 subdomain of the unliganded protein adopts the closed conformation seen in the structure of the protein in complex with inhibitors. This conformation is distinct from the open conformation of the subdomain seen when the protein is bound to ATP or ADP. ADP soaked into crystals of the unliganded protein reveals an intermediate conformation midway between the open and closed states and demonstrates that in GRP94 the conversion between the open and closed states is driven by ligand binding. The direction of the observed movement in GRP94 shows that nucleotides act to open the subdomain elements rather than close them, which is contrary to the motion proposed for Hsp90. These observations support a model where ATP binding dictates the conformation of the N-domain and regulates its ability to form quaternary structural interactions.
Journal of Molecular Biology | 2009
Robert M. Immormino; Louis E. Metzger; Patrick N. Reardon; D. Eric Dollins; Brian S. J. Blagg; Daniel T. Gewirth
Hsp90 chaperones contain an N-terminal ATP binding site that has been effectively targeted by competitive inhibitors. Despite the myriad of inhibitors, none to date have been designed to bind specifically to just one of the four mammalian Hsp90 paralogs, which are cytoplasmic Hsp90alpha and beta, endoplasmic reticulum GRP94, and mitochondrial Trap-1. Given that each of the Hsp90 paralogs is responsible for chaperoning a distinct set of client proteins, specific targeting of one Hsp90 paralog may result in higher efficacy and therapeutic control. Specific inhibitors may also help elucidate the biochemical roles of each Hsp90 paralog. Here, we present side-by-side comparisons of the structures of yeast Hsp90 and mammalian GRP94, bound to the pan-Hsp90 inhibitors geldanamycin (Gdm) and radamide. These structures reveal paralog-specific differences in the Hsp90 and GRP94 conformations in response to Gdm binding. We also report significant variation in the pose and disparate binding affinities for the Gdm-radicicol chimera radamide when bound to the two paralogs, which may be exploited in the design of paralog-specific inhibitors.
Journal of Structural and Functional Genomics | 2009
Jeffrey J. Headd; Robert M. Immormino; Daniel A. Keedy; Paul Emsley; David C. Richardson; Jane S. Richardson
Misfit sidechains in protein crystal structures are a stumbling block in using those structures to direct further scientific inference. Problems due to surface disorder and poor electron density are very difficult to address, but a large class of systematic errors are quite common even in well-ordered regions, resulting in sidechains fit backwards into local density in predictable ways. The MolProbity web site is effective at diagnosing such errors, and can perform reliable automated correction of a few special cases such as 180° flips of Asn or Gln sidechain amides, using all-atom contacts and H-bond networks. However, most at-risk residues involve tetrahedral geometry, and their valid correction requires rigorous evaluation of sidechain movement and sometimes backbone shift. The current work extends the benefits of robust automated correction to more sidechain types. The Autofix method identifies candidate systematic, flipped-over errors in Leu, Thr, Val, and Arg using MolProbity quality statistics, proposes a corrected position using real-space refinement with rotamer selection in Coot, and accepts or rejects the correction based on improvement in MolProbity criteria and on χ angle change. Criteria are chosen conservatively, after examining many individual results, to ensure valid correction. To test this method, Autofix was run and analyzed for 945 representative PDB files and on the 50S ribosomal subunit of file 1YHQ. Over 40% of Leu, Val, and Thr outliers and 15% of Arg outliers were successfully corrected, resulting in a total of 3,679 corrected sidechains, or 4 per structure on average. Summary Sentences: A common class of misfit sidechains in protein crystal structures is due to systematic errors that place the sidechain backwards into the local electron density. A fully automated method called “Autofix” identifies such errors for Leu, Val, Thr, and Arg and corrects over one third of them, using MolProbity validation criteria and Coot real-space refinement of rotamers.
International Tables for Crystallography | 2012
Vincent B. Chen; W. B. Arendall; Jeffrey J. Headd; Daniel A. Keedy; Robert M. Immormino; Gary J. Kapral; Laura Weston Murray; Jane S. Richardson; David C. Richardson
MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids. It relies heavily on the power and sensitivity provided by optimized H-atom placement and all-atom contact analysis, complemented by updated versions of covalent-geometry and torsion-angle criteria. Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding. X-ray crystallography provides a wealth of biologically important molecular data in the form of atomic three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states. Advances in automation, in everything from crystallization to data collection to phasing to model building to refinement, have made solving a structure using crystallography easier than ever. However, despite these improvements, local errors that can affect biological interpretation are widespread at low resolution and even high-resolution structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers. It is critical both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures. MolProbity is the authors’ contribution to helping solve this problem and this chapter reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database. Keywords: all-atom contacts; clashscore; automated correction; KiNG; MolProbity; ribose pucker; Ramachandran plots; side-chain rotamers; model quality; systematic errors; database improvement
Molecular Cell | 2007
D. Eric Dollins; Joshua J. Warren; Robert M. Immormino; Daniel T. Gewirth
RNA | 2008
Jane S. Richardson; Bohdan Schneider; Laura Weston Murray; Gary J. Kapral; Robert M. Immormino; Jeffrey J. Headd; David C. Richardson; Daniela Ham; Eli Hershkovits; Loren Dean Williams; Kevin S. Keating; Anna Marie Pyle; David Micallef; John D. Westbrook; Helen M. Berman
Journal of Medicinal Chemistry | 2006
Huazhong He; Danuta Zatorska; Joungnam Kim; Julia Aguirre; Laura Llauger; Yuhong She; Nian Wu; Robert M. Immormino; Daniel T. Gewirth; Gabriela Chiosis
Journal of Biological Chemistry | 2004
Robert M. Immormino; D. Eric Dollins; Paul L. Shaffer; Karen Soldano; Melissa A. Walker; Daniel T. Gewirth
Journal of Medicinal Chemistry | 2006
Robert M. Immormino; Yanlong Kang; Gabriela Chiosis; Daniel T. Gewirth